Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mogamulizumab plus CHOP regimen in cancer (Japan, Phase 2)
jRCT1080223952Phase 2Completed
- Start
- Jun 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of mogamulizumab in cancer. Started Jun 2018; status: completed.
02
Drugs
mogamulizumab
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT1080223952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223952.